Minimum Bio specializes in biotechnology, focusing on improving drug discovery processes to reduce the time and cost of preclinical R&D. The company has developed a platform that links drugs with their protein targets, enabling rapid and unbiased determination of the proteins that drugs or drug leads bind to. This technology aims to streamline the drug discovery process and enhance the efficiency of identifying new therapeutic targets.